Jaime Gomez–Millan Barrachina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jaime Gomez–Millan Barrachina has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Perez-Rozos
IMOMA
1 shared publication Alicia Roman
Department of Radiation Oncology, University Hospital Virgen de la Victoria, Malaga, Spain
1 shared publicationEloisa Bayo
Department of Radiation Oncology, University Hospital Juan Ramón Jiménez, Huelva, Spain
1 shared publicationEsperanza Torres
Department of Medical Oncology, University Hospital Virgen de la Victoria, Málaga, Spain
1 shared publicationFernando De la Portilla
Department of Surgery, Colorectal Surgery, University Hospital Virgen del Rocío, Seville, Spain
1 shared publicationInmaculada Jerez Sainz
Department of Radiation Oncology (Medical Physics Unit), University Hospital Virgen de la Victoria, Malaga
1 shared publication
Latest Publications
- 23 March 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 115 (3) , 301-306
The impact of body mass index and nuclear β‐catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy
Background and Objective: We examined the prognostic value of obesity and nuclear β‐catenin in patients with locally advanced rectal cancer.Methods: We prospectively recruited a total of 98 eligible patients with locally advanced cancer for preoperative radiochemotherapy followed by total mesorectal excision. Patients’ height and weight were reaorded before radiochemotherapy, and the immunohistochemical expression of nuclear β‐catenin was analyzed. Disease‐free survival (DFS) was analyzed using the Kaplan–Meier method and a Cox regression model was employed for the multivariate analysis.Results: Obese patients were associated with a lower number of recurrences (3.6% vs. 34.3%, P = 0.001), and a higher DFS (95% vs. 53%; HR, 0.09; 95%CI, 0.01–0.64; P = 0.005) than non‐obese patients. In the multivariate analysis, body mass index, nuclear β‐catenin expression, and the absence of lymph node metastases showed a significant increase in DFS.Conclusions: Obesity and nuclear β‐catenin are independent favorable prognostic factors for DFS in locally advanced cancer treated with preoperative radiochemotherapy. J. Surg. Oncol. 2017;115:301–306.
- 23 March 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 115 (3) , 301-306
The impact of body mass index and nuclear β‐catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy
Background and Objective: We examined the prognostic value of obesity and nuclear β‐catenin in patients with locally advanced rectal cancer.Methods: We prospectively recruited a total of 98 eligible patients with locally advanced cancer for preoperative radiochemotherapy followed by total mesorectal excision. Patients’ height and weight were reaorded before radiochemotherapy, and the immunohistochemical expression of nuclear β‐catenin was analyzed. Disease‐free survival (DFS) was analyzed using the Kaplan–Meier method and a Cox regression model was employed for the multivariate analysis.Results: Obese patients were associated with a lower number of recurrences (3.6% vs. 34.3%, P = 0.001), and a higher DFS (95% vs. 53%; HR, 0.09; 95%CI, 0.01–0.64; P = 0.005) than non‐obese patients. In the multivariate analysis, body mass index, nuclear β‐catenin expression, and the absence of lymph node metastases showed a significant increase in DFS.Conclusions: Obesity and nuclear β‐catenin are independent favorable prognostic factors for DFS in locally advanced cancer treated with preoperative radiochemotherapy. J. Surg. Oncol. 2017;115:301–306.
- 30 April 2014
- Published by Wiley in Head & Neck
- Vol. 37 (6) , 909-914
Potential advantages of volumetric arc therapy in head and neck cancer
Background Intensity‐modulated radiation therapy (IMRT) uses solid compensators or multileaf collimators to modulate the intensity of radiation in each field, delivering highly conformal dose distributions. This technique allows treating volumes with concave shapes when the target is close to a critical structure. The movement of multileaf collimator under computer control can modulate the dose in 3 main ways: IMRT with static field with segments, IMRT with dynamic delivery, and IMRT rotational therapy. Volumetric modulated arc therapy (VMAT) is a novel radiation technique that creates conformal distributions with variable gantry speed, dynamic movements of multileaf collimator, and variations in dose rate. The purpose of this study was to review the basis of VMAT, highlighting the differences with other IMRT techniques. © 2014 Wiley Periodicals, Inc. Head Neck, 2014
- 30 April 2014
- Published by Wiley in Head & Neck
- Vol. 37 (6) , 909-914
Potential advantages of volumetric arc therapy in head and neck cancer
Background Intensity‐modulated radiation therapy (IMRT) uses solid compensators or multileaf collimators to modulate the intensity of radiation in each field, delivering highly conformal dose distributions. This technique allows treating volumes with concave shapes when the target is close to a critical structure. The movement of multileaf collimator under computer control can modulate the dose in 3 main ways: IMRT with static field with segments, IMRT with dynamic delivery, and IMRT rotational therapy. Volumetric modulated arc therapy (VMAT) is a novel radiation technique that creates conformal distributions with variable gantry speed, dynamic movements of multileaf collimator, and variations in dose rate. The purpose of this study was to review the basis of VMAT, highlighting the differences with other IMRT techniques. © 2014 Wiley Periodicals, Inc. Head Neck, 2014